Turgeon Joseph W. 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Turgeon Joseph W.
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.001 par value
2020-03-12+282,427→ 697,695 total - Award
Stock Option (Right to Buy)
2020-03-12+450,000→ 450,000 totalExercise: $2.13Exp: 2030-03-12→ Common Stock (450,000 underlying) - Award
Stock Appreciation Right
2020-03-12+600,000→ 600,000 totalExercise: $2.13Exp: 2030-03-12→ Common Stock (600,000 underlying)
Holdings
- 1,538(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of March 12, 2021, 2022 and 2023, respectively.
- [F2]25% of the option shares vested on March 12, 2020. The remaining option shares shall vest in equal amounts of 25% of the total shares underlying the option shares on each anniversary of the grant date over the next three years.
- [F3]25% of the stock appreciation rights vested on March 12, 2020. The remaining stock appreciation rights shall vest in equal amounts of 25% of the total shares underlying the stock appreciation rights on each anniversary of the grant date over the next three years. The stock appreciation rights can be settled in common stock or cash at the election of the Compensation Committee.